Literature DB >> 28049734

Sphingosine and Sphingosine Kinase 1 Involvement in Endocytic Membrane Trafficking.

Santiago Lima1, Sheldon Milstien2, Sarah Spiegel3.   

Abstract

The balance between cholesterol and sphingolipids within the plasma membrane has long been implicated in endocytic membrane trafficking. However, in contrast to cholesterol functions, little is still known about the roles of sphingolipids and their metabolites. Perturbing the cholesterol/sphingomyelin balance was shown to induce narrow tubular plasma membrane invaginations enriched with sphingosine kinase 1 (SphK1), the enzyme that converts the bioactive sphingolipid metabolite sphingosine to sphingosine-1-phosphate, and suggested a role for sphingosine phosphorylation in endocytic membrane trafficking. Here we show that sphingosine and sphingosine-like SphK1 inhibitors induced rapid and massive formation of vesicles in diverse cell types that accumulated as dilated late endosomes. However, much smaller vesicles were formed in SphK1-deficient cells. Moreover, inhibition or deletion of SphK1 prolonged the lifetime of sphingosine-induced vesicles. Perturbing the plasma membrane cholesterol/sphingomyelin balance abrogated vesicle formation. This massive endosomal influx was accompanied by dramatic recruitment of the intracellular SphK1 and Bin/Amphiphysin/Rvs domain-containing proteins endophilin-A2 and endophilin-B1 to enlarged endosomes and formation of highly dynamic filamentous networks containing endophilin-B1 and SphK1. Together, our results highlight the importance of sphingosine and its conversion to sphingosine-1-phosphate by SphK1 in endocytic membrane trafficking.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  endocytosis; endosome; sphingolipid; sphingosine; sphingosine kinase (SphK); sphingosine-1-phosphate (S1P)

Mesh:

Substances:

Year:  2017        PMID: 28049734      PMCID: PMC5336145          DOI: 10.1074/jbc.M116.762377

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  76 in total

Review 1.  Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis.

Authors:  Volker Brinkmann; Andreas Billich; Thomas Baumruker; Peter Heining; Robert Schmouder; Gordon Francis; Shreeram Aradhye; Pascale Burtin
Journal:  Nat Rev Drug Discov       Date:  2010-10-29       Impact factor: 84.694

Review 2.  Endocytosis and autophagy: exploitation or cooperation?

Authors:  Sharon A Tooze; Adi Abada; Zvulun Elazar
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-05-01       Impact factor: 10.005

3.  The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2.

Authors:  Steven W Paugh; Shawn G Payne; Suzanne E Barbour; Sheldon Milstien; Sarah Spiegel
Journal:  FEBS Lett       Date:  2003-11-06       Impact factor: 4.124

4.  Coordinated actions of actin and BAR proteins upstream of dynamin at endocytic clathrin-coated pits.

Authors:  Shawn M Ferguson; Shawn Ferguson; Andrea Raimondi; Summer Paradise; Hongying Shen; Kumi Mesaki; Agnes Ferguson; Olivier Destaing; Genevieve Ko; Junko Takasaki; Ottavio Cremona; Eileen O' Toole; Pietro De Camilli
Journal:  Dev Cell       Date:  2009-12       Impact factor: 12.270

5.  Sphingosine kinases and their metabolites modulate endolysosomal trafficking in photoreceptors.

Authors:  Ikuko Yonamine; Takeshi Bamba; Niraj K Nirala; Nahid Jesmin; Teresa Kosakowska-Cholody; Kunio Nagashima; Eiichiro Fukusaki; Jairaj K Acharya; Usha Acharya
Journal:  J Cell Biol       Date:  2011-02-14       Impact factor: 10.539

6.  Altering sphingolipid metabolism in Saccharomyces cerevisiae cells lacking the amphiphysin ortholog Rvs161 reinitiates sugar transporter endocytosis.

Authors:  Jeanelle Morgan; Paula McCourt; Lauren Rankin; Evelyn Swain; Lyndi M Rice; Joseph T Nickels
Journal:  Eukaryot Cell       Date:  2009-03-13

Review 7.  Endocytosis and signaling: cell logistics shape the eukaryotic cell plan.

Authors:  Sara Sigismund; Stefano Confalonieri; Andrea Ciliberto; Simona Polo; Giorgio Scita; Pier Paolo Di Fiore
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

8.  Coupling between endocytosis and sphingosine kinase 1 recruitment.

Authors:  Hongying Shen; Francesca Giordano; Yumei Wu; Jason Chan; Chen Zhu; Ira Milosevic; Xudong Wu; Kai Yao; Bo Chen; Tobias Baumgart; Derek Sieburth; Pietro De Camilli
Journal:  Nat Cell Biol       Date:  2014-06-15       Impact factor: 28.824

9.  Search for inhibitors of endocytosis: Intended specificity and unintended consequences.

Authors:  Dipannita Dutta; Julie G Donaldson
Journal:  Cell Logist       Date:  2012-10-01

10.  Endophilin B1 is required for the maintenance of mitochondrial morphology.

Authors:  Mariusz Karbowski; Seon-Yong Jeong; Richard J Youle
Journal:  J Cell Biol       Date:  2004-09-27       Impact factor: 10.539

View more
  28 in total

Review 1.  Lipidomics in translational research and the clinical significance of lipid-based biomarkers.

Authors:  Daniel J Stephenson; L Alexis Hoeferlin; Charles E Chalfant
Journal:  Transl Res       Date:  2017-06-15       Impact factor: 7.012

Review 2.  Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.

Authors:  Jeremy Shaw; Pedro Costa-Pinheiro; Logan Patterson; Kelly Drews; Sarah Spiegel; Mark Kester
Journal:  Adv Cancer Res       Date:  2018-06-19       Impact factor: 6.242

3.  TP53 is required for BECN1- and ATG5-dependent cell death induced by sphingosine kinase 1 inhibition.

Authors:  Santiago Lima; Kazuaki Takabe; Jason Newton; Kumar Saurabh; Megan M Young; Andreia Machado Leopoldino; Nitai C Hait; Jane L Roberts; Hong-Gang Wang; Paul Dent; Sheldon Milstien; Laurence Booth; Sarah Spiegel
Journal:  Autophagy       Date:  2018-03-11       Impact factor: 16.016

4.  Examination of the role of sphingosine kinase 2 in a murine model of systemic lupus erythematosus.

Authors:  Sabira Mohammed; Nalanda S Vineetha; Shirley James; Jayasekharan S Aparna; Manendra Babu Lankadasari; Jeremy C Allegood; Quan-Zhen Li; Sarah Spiegel; Kuzhuvelil B Harikumar
Journal:  FASEB J       Date:  2019-03-06       Impact factor: 5.191

5.  Sphingosine Kinase 2 Potentiates Amyloid Deposition but Protects against Hippocampal Volume Loss and Demyelination in a Mouse Model of Alzheimer's Disease.

Authors:  Mona Lei; Jonathan D Teo; Huitong Song; Holly P McEwen; Jun Yup Lee; Timothy A Couttas; Thomas Duncan; Rose Chesworth; Josefine Bertz; Magdalena Przybyla; Janet Van Eersel; Benjamin Heng; Gilles J Guillemin; Lars M Ittner; Thomas Fath; Brett Garner; Arne Ittner; Tim Karl; Anthony S Don
Journal:  J Neurosci       Date:  2019-10-22       Impact factor: 6.167

6.  A simple method for sphingolipid analysis of tissues embedded in optimal cutting temperature compound.

Authors:  Timothy D Rohrbach; April E Boyd; Pamela J Grizzard; Sarah Spiegel; Jeremy Allegood; Santiago Lima
Journal:  J Lipid Res       Date:  2020-04-27       Impact factor: 5.922

7.  Targeting defective sphingosine kinase 1 in Niemann-Pick type C disease with an activator mitigates cholesterol accumulation.

Authors:  Jason Newton; Elisa N D Palladino; Cynthia Weigel; Michael Maceyka; Markus H Gräler; Can E Senkal; Ricardo D Enriz; Pavlina Marvanova; Josef Jampilek; Santiago Lima; Sheldon Milstien; Sarah Spiegel
Journal:  J Biol Chem       Date:  2020-05-08       Impact factor: 5.157

8.  Sphingosine Kinase Regulates Neuropeptide Secretion During the Oxidative Stress-Response Through Intertissue Signaling.

Authors:  Sungjin Kim; Derek Sieburth
Journal:  J Neurosci       Date:  2018-08-06       Impact factor: 6.167

9.  Regulatory role of SphK1 in TLR7/9-dependent type I interferon response and autoimmunity.

Authors:  Sabira Mohammed; Nalanda S Vineetha; Shirley James; Jayasekharan S Aparna; Manendra Babu Lankadasari; Takahiro Maeda; Abhirupa Ghosh; Sudipto Saha; Quan-Zhen Li; Sarah Spiegel; Kuzhuvelil B Harikumar
Journal:  FASEB J       Date:  2020-01-23       Impact factor: 5.191

Review 10.  Niemann-Pick type C disease: The atypical sphingolipidosis.

Authors:  Jason Newton; Sheldon Milstien; Sarah Spiegel
Journal:  Adv Biol Regul       Date:  2018-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.